swish30

DVAX - Potential continuation play intraday

看多
NASDAQ:DVAX   Dynavax Technologies Corporation
Advisory committee has voted in favour of Hepatitis-B vaccine. Now just waiting for FDA approval expected no later than November 10.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。